CELC compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name

CELCCelcuity Inc.

Mkt capRevenueRevenue

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

CELCCelcuity Inc.

MDGLMadrigal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CELCCelcuity Inc.

69.27▼−0.05%· post 69.27

Mkt cap$3.4BRevenue—Revenue—

MDGLMadrigal Pharmaceuticals, Inc.

430.17▼−0.35%· post 433.06

ClosedOct 30 '26

Mkt cap$9.9BRevenue$364MQ2 FY26Revenue$958MFY25

Compare

ClosedOct 30 '26

CELCCelcuity Inc.

MDGLMadrigal Pharmaceuticals, Inc.

69.27▼−0.05%post 69.27

Price

430.17▼−0.35%post 433.06

$3.4B

Mkt cap

$9.9B

—

Revenue

$364MQ2 FY26

—

Revenue

$958MFY25

CELC69.27▼−0.05%vsMDGL430.17▼−0.35%ClosedOct 30 '26

Earnings history

last 4 reports each · paired by recencyMethod ›

CELC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±7.9%▲+6.24%×0.78

May 15 '26±5.1%▲+2.20%×0.43

Q1 FY26±13.0%▲+4.16%×0.32

Q3 FY25±8.9%▲+1.00%×0.11

MDGL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.5%▼−9.83%×0.93

Q1 FY26±9.2%▲+7.42%×0.80

= impliedCELC realized, solidMDGL realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Feb 19 '26

±6.2%

▼−11.11%

×1.79

Nov 4 '25±12.9%▲+7.83%×0.60